CD4 and cancer: Notably, elevated proportions of CD4+CD25+ Treg in the total CD4+ T cell populations are present in the tumor microenvironment of various types of cancer where they mediate immune suppression via down regulating the functions of CD4+, CD8+, NK and NKT cells [47-49].